HRP20170497T1 - Postupak dobivanja nalmefen hidroklorida - Google Patents

Postupak dobivanja nalmefen hidroklorida Download PDF

Info

Publication number
HRP20170497T1
HRP20170497T1 HRP20170497TT HRP20170497T HRP20170497T1 HR P20170497 T1 HRP20170497 T1 HR P20170497T1 HR P20170497T T HRP20170497T T HR P20170497TT HR P20170497 T HRP20170497 T HR P20170497T HR P20170497 T1 HRP20170497 T1 HR P20170497T1
Authority
HR
Croatia
Prior art keywords
nalmefene hydrochloride
steps
aqueous
aqueous mixture
carried out
Prior art date
Application number
HRP20170497TT
Other languages
English (en)
Croatian (hr)
Inventor
Carla De Faveri
Mariano Stivanello
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48573602&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20170497(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of HRP20170497T1 publication Critical patent/HRP20170497T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HRP20170497TT 2011-12-06 2012-12-06 Postupak dobivanja nalmefen hidroklorida HRP20170497T1 (hr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161567148P 2011-12-06 2011-12-06
DKPA201100948 2011-12-06
EP12797909.4A EP2788357B1 (en) 2011-12-06 2012-12-06 Process for recovery of nalmefene hydrochloride
PCT/EP2012/074623 WO2013083685A1 (en) 2011-12-06 2012-12-06 Process for recovery of nalmefene hydrochloride

Publications (1)

Publication Number Publication Date
HRP20170497T1 true HRP20170497T1 (hr) 2017-06-02

Family

ID=48573602

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20170497TT HRP20170497T1 (hr) 2011-12-06 2012-12-06 Postupak dobivanja nalmefen hidroklorida

Country Status (32)

Country Link
US (1) US8841452B1 (enExample)
EP (1) EP2788357B1 (enExample)
JP (1) JP6086925B2 (enExample)
KR (1) KR20140103288A (enExample)
CN (1) CN104093721B (enExample)
AR (1) AR089080A1 (enExample)
AU (1) AU2012347261B2 (enExample)
BR (1) BR112014013541B1 (enExample)
CA (1) CA2857096C (enExample)
CL (1) CL2014001454A1 (enExample)
CO (1) CO6970605A2 (enExample)
CY (1) CY1118785T1 (enExample)
DK (1) DK2788357T3 (enExample)
ES (1) ES2622156T3 (enExample)
HR (1) HRP20170497T1 (enExample)
HU (1) HUE033717T2 (enExample)
IL (1) IL232826A (enExample)
IN (1) IN2014KN01211A (enExample)
JO (1) JO3251B1 (enExample)
LT (1) LT2788357T (enExample)
ME (1) ME02668B (enExample)
MX (1) MX354331B (enExample)
PL (1) PL2788357T3 (enExample)
PT (1) PT2788357T (enExample)
RS (1) RS55817B1 (enExample)
RU (1) RU2631652C2 (enExample)
SG (1) SG11201402956UA (enExample)
SI (1) SI2788357T1 (enExample)
SM (1) SMT201700200T1 (enExample)
TW (1) TWI560170B (enExample)
WO (1) WO2013083685A1 (enExample)
ZA (1) ZA201404100B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105646508B (zh) * 2016-02-17 2018-02-27 南京卓康医药科技有限公司 一种盐酸纳美芬一水合物的制备方法
US10927121B1 (en) 2019-12-20 2021-02-23 Southwest Research Institute Technologies for removing residual solvent from nalmefene hydrochloride and producing crystalline nalmefene hydrochloride monohydrate, monosolvate, or crystalline nalmefene hydrochloride dihydrate
WO2022165040A1 (en) 2021-01-28 2022-08-04 Rhodes Technologies Process for crystallizing nalmefene hydrochloride
CN117986261B (zh) * 2024-04-02 2024-06-18 成都瑞尔医药科技有限公司 一种盐酸纳美芬母液的回收套用方法
CN119080788A (zh) * 2024-08-19 2024-12-06 南京海鲸药业股份有限公司 一种盐酸纳美芬杂质的去除监控系统及去除方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2577947A (en) * 1951-12-11 Manufacture of dihydrocodeinone
US3896226A (en) 1971-11-26 1975-07-22 Lewinstein Evalina 6-methylene-6-desoxy dihydro morphine and codeine derivatives and pharmaceutically acceptable salts thereof, and use of the same as a narcotic antagonist
US3814768A (en) * 1971-11-26 1974-06-04 Lewenstein E 6-methylene-6-desoxy dihydro morphine and codeine derivatives and pharmaceutically acceptable salts
US4535157A (en) 1983-11-01 1985-08-13 Key Pharmaceuticals, Inc. Process for making 6-desoxy-6-methylenenaloxone and 6-desoxy-6-methylenenaltrexone
US4751307A (en) 1985-01-17 1988-06-14 Mallinckrodt, Inc. Wittig-reaction processes
US5869669A (en) * 1996-07-26 1999-02-09 Penick Corporation Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates
EP2003134B1 (en) * 1999-11-09 2011-03-02 Abbott Laboratories Hydromorphinone compositions
AU2003220290B2 (en) * 2002-03-14 2007-06-14 Euro-Celtique S.A. Naltrexone hydrochloride compositions
JP5695296B2 (ja) * 2006-03-02 2015-04-01 マリンクロッド エルエルシー 低レベルのアルファ,ベータ−不飽和ケトン化合物を伴うモルフィナン−6−オン生成物の製造方法
CN101652370A (zh) * 2006-12-04 2010-02-17 诺拉姆科有限公司 制备14-羟基可待因酮水平减少的羟考酮的方法
EP2121669A2 (en) 2007-01-30 2009-11-25 Biogen Idec MA, Inc. Furanone compounds and methods of making and using the same
UA102128C2 (en) * 2008-12-05 2013-06-10 Х. Луннбек А/С Nalmefene hydrochloride dihydrate
EA019331B1 (ru) * 2009-05-25 2014-02-28 Х. Лундбекк А/С Получение налмефена гидрохлорида из налтрексона
CN101768164B (zh) * 2010-01-25 2011-09-14 海南数尔药物研究有限公司 一种高纯度的盐酸纳洛酮化合物

Also Published As

Publication number Publication date
PL2788357T3 (pl) 2017-07-31
AR089080A1 (es) 2014-07-30
RS55817B1 (sr) 2017-08-31
US20140296525A1 (en) 2014-10-02
LT2788357T (lt) 2017-04-25
CO6970605A2 (es) 2014-06-13
ZA201404100B (en) 2015-11-25
IL232826A (en) 2016-10-31
WO2013083685A1 (en) 2013-06-13
EP2788357A1 (en) 2014-10-15
JP2015504856A (ja) 2015-02-16
SMT201700200T1 (it) 2017-05-08
MX2014006705A (es) 2014-07-09
TWI560170B (en) 2016-12-01
BR112014013541B1 (pt) 2022-02-15
CY1118785T1 (el) 2017-07-12
HK1202874A1 (en) 2015-10-09
US8841452B1 (en) 2014-09-23
AU2012347261A1 (en) 2014-06-19
CL2014001454A1 (es) 2014-10-03
JP6086925B2 (ja) 2017-03-01
IN2014KN01211A (enExample) 2015-10-16
RU2014126489A (ru) 2016-01-27
SG11201402956UA (en) 2014-07-30
TW201335110A (zh) 2013-09-01
SI2788357T1 (sl) 2017-06-30
DK2788357T3 (en) 2017-04-24
JO3251B1 (ar) 2018-09-16
CN104093721B (zh) 2016-05-18
IL232826A0 (en) 2014-08-03
KR20140103288A (ko) 2014-08-26
CA2857096A1 (en) 2013-06-13
RU2631652C2 (ru) 2017-09-26
ES2622156T3 (es) 2017-07-05
MX354331B (es) 2018-02-27
CA2857096C (en) 2021-01-19
HUE033717T2 (en) 2017-12-28
ME02668B (me) 2017-06-20
CN104093721A (zh) 2014-10-08
PT2788357T (pt) 2017-04-24
AU2012347261B2 (en) 2016-12-01
BR112014013541A2 (pt) 2017-06-13
EP2788357B1 (en) 2017-03-01

Similar Documents

Publication Publication Date Title
JP2011126894A5 (enExample)
PE20141160A1 (es) Metodos para preparar analogos nucleotidicos antivirales
WO2012112735A3 (en) Separation of a target substance from a fluid or mixture using encapsulated sorbents
MY167395A (en) Method for producing glufosinate p free acid
ME02316B (me) Imidazopiridazini kao inhibitori akt kinaze
ME02668B (me) Postupak za izdvajanje nalmefen hidrohlorida
JP2017501141A5 (enExample)
HRP20171167T1 (hr) Priprava intermedijera pirimidina koji služe za proizvodnju macitentana
Cho et al. Palladium-catalyzed construction of poly-substituted indolizinones
WO2013112884A3 (en) Method for purification of silicon
WO2013079507A3 (de) Verfahren zur herstellung und aufreinigung von salzen der acrylamido-2-methyl-propansulfonsäure
WO2013043009A3 (ko) 1-팔미토일-3-아세틸글리세롤의 제조방법 및 이를 이용한 1-팔미토일-2-리놀레오일-3-아세틸글리세롤의 제조방법
JP2013100237A5 (enExample)
WO2014041566A3 (en) Improved process for the preparation of metformin hydrochloride
ME02621B (me) Postupak za proizvodnju naltreksona
WO2014068333A3 (en) New process
WO2017039112A3 (ko) 수처리 분리막의 제조방법, 이를 이용하여 제조된 수처리 분리막, 및 수처리 분리막을 포함하는 수처리 모듈
CN104031088A (zh) 一种α-氨基烷基膦化物的合成方法
WO2013016557A3 (en) Methods of isolating 4-chloro-2-fluoro-3-substituted-phenylboronic acids
JP2014528896A5 (enExample)
BR112016024977A2 (pt) processo para a preparação de polimorfos de imidacloprida
HRP20171166T1 (hr) Postupak za pripravu intermedijera pirimidina
JP2016525094A5 (enExample)
CN105272854A (zh) 一种吉法酯的制备方法
TH149358A (th) การสกัดของกรดพอลิคาร์บอกซิลิค